Literature DB >> 1853557

Transfer of the hemagglutinin activity of influenza virus neuraminidase subtype N9 into an N2 neuraminidase background.

J M Nuss1, G M Air.   

Abstract

It has previously been shown that influenza virus neuraminidase (NA) of the N9 subtype is unusual in that it possesses hemagglutinin activity as well as NA activity. Loss of red cell binding in certain escape mutants suggested that the hemagglutinating site is separate from the NA active site and involves at least two of the polypeptide loops found on the surface of the molecule (Webster et al., 1987. J. Virol. 61, 2910-2916). We have used site-directed mutagenesis to transfer the amino acids in these loops at positions 368-370 and 399-403 of N9 NA (A/tern/Australia/G70c/75), separately and together, into subtype N2 NA (A/Tokyo/3/67). The three mutant proteins were expressed from an SV40 transient expression system (Fuerst et al., 1986. Proc. Natl. Acad. Sci. USA. 83, 8122-8126). The mutant which contained both loops of N9 NA had acquired the hemagglutinin activity of N9. The agglutinated red cells are released by the enzyme activity of N9 NA, indicating that the agglutination involves binding to sialic acid in the same configuration as does the parental N9 NA, and an inhibitor of NA did not affect hemagglutination, indicating that this site is separate from the NA site as in parental N9.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1853557     DOI: 10.1016/0042-6822(91)90979-l

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  18 in total

1.  Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).

Authors:  Upma Gulati; Chi-Ching Hwang; Lalitha Venkatramani; Shelly Gulati; Stephen J Stray; Janis T Lee; W Graeme Laver; Alexey Bochkarev; Adam Zlotnick; Gillian M Air
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

2.  Mutation at residue 523 creates a second receptor binding site on human parainfluenza virus type 1 hemagglutinin-neuraminidase protein.

Authors:  Tatiana Bousse; Toru Takimoto
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases.

Authors:  J N Varghese; P M Colman; A van Donkelaar; T J Blick; A Sahasrabudhe; J L McKimm-Breschkin
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

Review 4.  Influenza Neuraminidase: Underrated Role in Receptor Binding.

Authors:  Feng Wen; Xiu-Feng Wan
Journal:  Trends Microbiol       Date:  2019-03-29       Impact factor: 17.079

5.  Antibody Determinants of Influenza Immunity.

Authors:  James E Crowe
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

6.  Sialidase of swine influenza A viruses: variation of the recognition specificities for sialyl linkages and for the molecular species of sialic acid with the year of isolation.

Authors:  G Xu; T Suzuki; Y Maejima; T Mizoguchi; M Tsuchiya; M Kiso; A Hasegawa; Y Suzuki
Journal:  Glycoconj J       Date:  1995-04       Impact factor: 2.916

7.  Mutations in the cytoplasmic tail of influenza A virus neuraminidase affect incorporation into virions.

Authors:  P Bilsel; M R Castrucci; Y Kawaoka
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

8.  Role of secondary sialic acid binding sites in influenza N1 neuraminidase.

Authors:  Jeffrey C Sung; Adam W Van Wynsberghe; Rommie E Amaro; Wilfred W Li; J Andrew McCammon
Journal:  J Am Chem Soc       Date:  2010-03-10       Impact factor: 15.419

9.  Comparison of the Efficacy of N9 Neuraminidase-Specific Monoclonal Antibodies against Influenza A(H7N9) Virus Infection.

Authors:  Hongquan Wan; Li Qi; Jin Gao; Laura K Couzens; Lianlian Jiang; Yamei Gao; Zong-Mei Sheng; Sharon Fong; Megan Hahn; Surender Khurana; Jeffery K Taubenberger; Maryna C Eichelberger
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

Review 10.  New aspects of influenza viruses.

Authors:  M W Shaw; N H Arden; H F Maassab
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.